Sex: M
Vaccine: COVID19
Symptoms: Bladder scan, Myelitis transverse
Clinical narrative: TRANSVERSE MYELITIS RELATED TO AN IMMUNE SYSTEM CHALLENGE; This spontaneous report received from a lawyer via a company representative concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient was very healthy and physically active male. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, 1 total administered on 06-MAY-2021 for prophylactic vaccination.  The batch number was not reported and has been requested. No concomitant medications were reported. On 08-MAY-2021, the patient began to experience weakness in his extremities, left greater than the right. He experienced significant left-sided abdominal pain. He found these acute symptoms extremely concerning and he went to the emergency department. After being evaluated in the emergency department, he was admitted on 15-MAY-2021 and discharged on 19-MAY-2021 to evaluate the new onset of left-sided weakness. The neurosurgery at the hospital felt that the symptoms were likely related to an autoimmune or inflammatory process after receiving the vaccine. Intravenous fluids and steroids were administered to the patient. On 27-May-2021, after being home for a week, he was again hospitalized at the same hospital due to worsening of bilateral upper and lower extremity weakness. After he completed his oral steroid taper at home, his symptoms returned, progressively ascending from his toes up. Upon return to the hospital, he was unable to ambulate or hold items in either hand. He also had urinary retention and no longer could feel an urge to urinate. This required him to undergo frequent bladder scans (results not provided) and catheterization to drain his bladder. He was diagnosed with transverse myelitis related to an immune system challenge from the vaccine. The patient received five doses of IVIG (intravenous immunoglobulin), a pooled antibody used for multiple autoimmune, inflammatory and infectious conditions. He again received steroids. On 03-JUN-2021, the patient was transferred to rehabilitation hospital and remained there until 19-JUN-2021, received intensive rehabilitation and education on how to independently drain his bladder by self-catheterization. On discharge, he went home with home health care and supplies to intermittently self-catheterize and a rolling walker for ambulation. At the time of reporting, the patient still had leg numbness, torso numbness and left-hand numbness. His left hand did not function properly. Due to the vaccine injuries and subsequent required medical care, he suffered from depression and hopelessness and financial concerns. The vaccine caused serious pain, disfigurement, paralysis, mental anguish and other damages and was experiencing these at the time of reporting as well. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of transverse myelitis related to an immune system challenge was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:  Medical Assessment comment not required as per standard operating procedure for legal case.